Journal of Medicinal Chemistry p. 1470 - 1476 (1990)
Update date:2022-08-04
Topics:
Cavalleri
Turconi
Tamborini
Occelli
Cietto
Pallanza
Scotti
Berti
Romano
Parenti
A series of derivatives of rifamycin P, an antibiotic produced by fermentation of a mutant strain of Nocardia mediterranea or by chemical modification of rifamycin S, have been prepared. The structures of these compounds were determined by 1H NMR, IR, UV, and LC/MS. Their in vitro and in vivo antibacterial activities in comparison with rifampicin and two other rifamycins under investigation were evaluated. The derivatives were more active than rifamycin P against Mycobacterium avium complex and other slowly and rapidly growing nontuberculous mycobacteria which frequently cause systemic infection in patients with AIDS. 2'-(Diethylamino)rifamycin P (P/DEA) appears suitable for further investigation.
View MoreChongqing Shuangfeng Chemical Co.,Ltd
Contact:+86-23-49850156
Address:No.663,xuanhua Rd,yongchuan,chongqing,China
Suzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
Contact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
Contact:86-21-50966856
Address:Building 5,300 Chuanzhan Road,Pudong New District,Shanghai
Doi:10.1002/hlca.19560390524
(1956)Doi:10.1016/j.tet.2008.12.016
(2009)Doi:10.1021/jo00242a049
(1988)Doi:10.1039/c5cc03421c
(2015)Doi:10.1039/C39870000662
(1987)Doi:10.1021/ol802946p
(2009)